Cresco, a publicly traded, vertically integrated cannabis and medical marijuana company, recently reported its third quarter earnings. The company met expectations for EDITDA, but slightly missed on revenue, and reported a pretty significant widening of losses this year compared to the same time last year. Charlie Bachtell, CEO of Cresco Labs, joined Cheddar to explain what happened and his hopes for the future of the company.
